 Shares of Kala Pharmaceuticals Inc NASDAQ:KALA have received a consensus recommendation of Buy from the nine ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month ... 